Boston Scientific Corporation logo

Boston Scientific Corporation (BSX)

Market Closed
10 Aug, 20:00
NYSE NYSE
$
50. 46
+1.15
+2.3322%
$
70.96B Market Cap
74.55 P/E Ratio
- Div Yield
18.99M Volume
2.01 Eps
$ 49.31
Previous Close
Add Transaction
Day Range
49.54 50.82
Year Range
42.2 109.5
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Boston Scientific Slashes Guidance; Why Shares Rallied

Boston Scientific Slashes Guidance; Why Shares Rallied

Boston Scientific stock rallied Wednesday despite cutting its 2026 outlook. An analyst says this could offer a reset for shares.

Investors | 3 months ago
Boston Scientific (BSX) Q1 Earnings Match Estimates

Boston Scientific (BSX) Q1 Earnings Match Estimates

Boston Scientific (BSX) came out with quarterly earnings of $0.8 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.75 per share a year ago.

Zacks | 3 months ago
Boston Scientific cuts 2026 profit forecast, trims revenue growth view

Boston Scientific cuts 2026 profit forecast, trims revenue growth view

Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while its shares were ​little changed after earlier volatility.

Reuters | 3 months ago
Boston Scientific Net Grows Sharply

Boston Scientific Net Grows Sharply

Boston Scientific said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, catheters and other cardiology devices.

Wsj | 3 months ago
CPC Advisors LLC Sells 27,747 Shares of Boston Scientific Corporation $BSX

CPC Advisors LLC Sells 27,747 Shares of Boston Scientific Corporation $BSX

CPC Advisors LLC lowered its holdings in Boston Scientific Corporation (NYSE: BSX) by 54.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,851 shares of the medical equipment provider's stock after selling 27,747 shares during the

Defenseworld | 3 months ago
Top Wall Street Forecasters Revamp Boston Scientific Expectations Ahead Of Q1 Earnings

Top Wall Street Forecasters Revamp Boston Scientific Expectations Ahead Of Q1 Earnings

Boston Scientific Corporation (NYSE:BSX) will release earnings for its first quarter before the opening bell on Wednesday, April 22.

Benzinga | 3 months ago
Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

Boston Scientific (NYSE: BSX) trades around $61, with analyst price targets ranging from $69 (conservative) to $124 (optimistic), implying substantial upside.

247wallst | 3 months ago
Will Robust Cardiovascular Performance Fuel BSX's Q1 Earnings?

Will Robust Cardiovascular Performance Fuel BSX's Q1 Earnings?

Boston Scientific heads into Q1 earnings with strong Cardiovascular momentum and steady MedSurg growth, as estimates point to solid revenue and earnings gains.

Zacks | 3 months ago
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.

Zacks | 3 months ago
Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know

Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know

Boston Scientific (BSX) closed the most recent trading day at $64.61, moving +1.24% from the previous trading session.

Zacks | 3 months ago
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?

Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?

Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 3 months ago
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?

Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 3 months ago
Loading...
Load More